farnesol has been researched along with Palsy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramsky, O; Chapman, J; Grigoriadis, N; Karussis, D; Kloog, Y; Mizrachi-Koll, R; Niv, H | 1 |
1 other study(ies) available for farnesol and Palsy
Article | Year |
---|---|
The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.
Topics: Animals; Antigens, Surface; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Farnesol; Female; Lymphocyte Activation; Lymphocytes; Mice; Myelin Proteins; Myelin Sheath; Paralysis; ras Proteins; Salicylates; Survival Rate; Treatment Outcome | 2001 |